文献速递心血管乳腺US

AutoSTRAIN自动应变定量技术评估乳腺癌蒽环类化疗患者全局心功能

Assessment of Global Cardiac Function Using AutoSTRAIN Automatic Strain Quantitative Technology in Patients With Breast Cancer Undergoing Anthracycline-Based Chemotherapy.
PubMed 文献 · Ultrasound Med Biol · 2022-10-23

化疗组LV-GLS、LASR、LASCD、RVFWSL和RV4CSL分别显著下降15.6%、13.8%、19.8%、21.8%和13.2%(p<0.05),LASCT轻度升高但无统计学意义。结论提示左右心室收缩均受损,RVFWSL评估心脏毒性可能优于LV-GLS,左房储备和通道功能显著降低而泵功能轻度增加。

要点

  • 蒽环类化疗后LV-GLS、RVFWSL、RV4CSL及左房LASR、LASCD均显著降低。
  • RVFWSL较LV-GLS可能更优用于评估蒽环类心脏毒性。
  • 化疗后LV-GLS的影响因素改变,左房功能对其影响更大。

核心结论

  • 蒽环类化疗完成后左右心室收缩均受损,RVFWSL评估心脏毒性可能优于LV-GLS。
  • 左房储备和通道功能显著降低,泵功能轻度增加但无统计学意义。
  • 化疗后LV-GLS的影响因素与健康人不同,左房功能对LV-GLS影响更大。

研究设计与样本

  • 采用斑点追踪超声心动图(AutoSTRAIN自动应变定量技术)分析左室、右室及左房应变参数。

诊断标准与关键数值

  • 化疗组较对照组LV-GLS下降15.6%、LASR下降13.8%、LASCD下降19.8%、RVFWSL下降21.8%、RV4CSL下降13.2%(p<0.05)。
  • LASCT在化疗组轻度升高但无统计学意义(p>0.05)。
  • 对照组LV-GLS影响因素公式:LV-GLS = -18.73738541 + 0.13961 × LVIDd + 0.09672 × LASCD + 0.18113 × RVFWSL。
  • 化疗组LV-GLS影响因素公式:LV-GLS = -8.026302253 + 0.20811 × LASCD + 0.11084 × LASCT + 0.12153 × RVFWSL。

临床应用与阅片要点

  • 日常阅片可关注蒽环类化疗患者的RVFWSL和左房应变参数,辅助评估心脏毒性。
  • 报告时应结合LV-GLS、RVFWSL及左房应变综合判断,注意化疗后左房功能对LV-GLS影响增大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

In patients with breast cancer undergoing anthracycline-based chemotherapy, we investigated the deformational parameters of the left ventricle, right ventricle and left atrium, as well as the relationship between these parameters. Ninety-five patients with breast cancer who were treated with anthracycline-based chemotherapy were enrolled. The control group included 116 healthy female volunteers. Parameters including left ventricular global longitudinal strain (LV-GLS); right ventricular free wall longitudinal strain (RVFWSL) and global longitudinal strain (RV4CSL); and peak strain of the left atrium during LV systole (LASR), early LV diastole (LASCD) and late LV diastole (LASCT) were analyzed by speckle tacking echocardiography. LV-GLS, LASR, LASCD, RVFWSL and RV4CSL in the chemotherapy group decreased significantly by 15.6%, 13.8%, 19.8%, 21.8% and 13.2% (p < 0.05), respectively, when compared with the control group. LASCT was slightly increased in the chemotherapy group but the increase was not statistically significant (p > 0.05). Formulas for the influencing factors of LV-GLS were LV-GLS = -18.73738541 + 0.13961 × LVIDd + 0.09672 × LASCD + 0.18113 × RVFWSL in the control group and LV-GLS = -8.026302253 + 0.20811 × LASCD + 0.11084 × LASCT + 0.12153 × RVFWSL in the chemotherapy group. Both LV contraction and RV contraction were impaired after the completion of anthracycline-based therapy, and RVFWSL may be superior to LV-GLS in assessing cardiotoxicity. LA reserve and channel function were significantly reduced, while pump function was slightly increased. Compared with the results among healthy people, the influencing factor of LV-GLS varied after anthracycline treatment, and LA function had a greater impact on LV-GLS.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Gu, Wang, Jiang, et al. Assessment of Global Cardiac Function Using AutoSTRAIN Automatic Strain Quantitative Technology in Patients With Breast Cancer Undergoing Anthracycline-Based Chemotherapy. Ultrasound Med Biol. 2022. PMID: 36283937. doi:10.1016/j.ultrasmedbio.2022.09.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。